Repligen Corporation (NASDAQ: RGEN) will present at the BIO CEO & Investor Conference. The company's President and CEO, Walter C. Herlihy, Ph.D., will represent them at the event.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Repligen has been scheduled to give their presentation at 2:00pm (EST) on February 8, 2010. The event is being held in NYC at the Waldorf-Astoria Hotel. The presentation will be webcast both live and for replay through the company's website.
Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
